Stay updated with breaking news from Nasdaq Blph. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
StockNews.com started coverage on shares of Bellerophon Therapeutics (NASDAQ:BLPH – Free Report) in a research note published on Monday. The firm issued a hold rating on the biotechnology company’s stock. Bellerophon Therapeutics Price Performance NASDAQ:BLPH opened at $0.04 on Monday. Bellerophon Therapeutics has a one year low of $0.03 and a one year high of […]
StockNews.com assumed coverage on shares of Bellerophon Therapeutics (NASDAQ:BLPH – Free Report) in a report published on Sunday. The brokerage issued a hold rating on the biotechnology company’s stock. Bellerophon Therapeutics Stock Performance NASDAQ BLPH opened at $0.03 on Friday. The stock has a market capitalization of $404,079.20, a price-to-earnings ratio of -0.04 and a […]
StockNews.com started coverage on shares of Bellerophon Therapeutics (NASDAQ:BLPH – Free Report) in a research report released on Tuesday. The firm issued a hold rating on the biotechnology company’s stock. Bellerophon Therapeutics Price Performance BLPH stock opened at $0.03 on Tuesday. The company’s fifty day simple moving average is $0.22 and its 200 day simple […]
StockNews.com started coverage on shares of Bellerophon Therapeutics (NASDAQ:BLPH – Free Report) in a research report sent to investors on Tuesday morning. The brokerage issued a hold rating on the biotechnology company’s stock. Bellerophon Therapeutics Price Performance Shares of BLPH opened at $0.03 on Tuesday. Bellerophon Therapeutics has a twelve month low of $0.03 and […]
StockNews.com initiated coverage on shares of Bellerophon Therapeutics (NASDAQ:BLPH – Free Report) in a report issued on Monday. The brokerage issued a hold rating on the biotechnology company’s stock. Bellerophon Therapeutics Stock Performance BLPH opened at $0.04 on Monday. The stock has a market capitalization of $433,431.20, a P/E ratio of -0.03 and a beta […]